📰 Nanolute Technology News
Page 2 - Nanolute Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nanolute Technology. Real-time updates on events, politics, business and more.
January 24, 2022
SINGAPORE, Jan. 24, 2022 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of
January 24, 2022
SINGAPORE, Jan. 24, 2022 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its IMPRESSION (sIroliMus coated balloon angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION) randomized controlled trial (RCT), as it crosses the 50 per cent enrollment mark. IMPRESSION randomized trial enrolled its index patient...
January 24, 2022
SINGAPORE, Jan. 24, 2022 /PRNewswire/ - Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its - Report on The Eastern Herald
January 24, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
January 24, 2022
/PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its IMPRESSION (sIroliMus coated...
December 18, 2020
18 dicembre 2020 06:30 Fonte: Adnkronos #salute-e-benessere TAMPA, Fla., Dec. 17, 2020 /PRNewswire/ -- Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the MagicTouch SCB Sirolimus Coated Balloon Catheter, for the treatment of small coronary artery lesions in Coronary Artery Disease (CAD). The proposed indication for use includes "The MagicTouch SCB Sirolimus Coa...
December 17, 2020
(1) TAMPA, Fla., Dec. 17, 2020 /PRNewswire/ -- Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the MagicTouch SCB Sirolimus Coated Balloon Catheter, for the treatment of small coronary artery lesions in Coronary Artery Disease (CAD). The proposed indication for use includes "The MagicTouch SCB Sirolimus Coated Balloon Catheter is indicated for percutaneous trans...